|Age:||18 years and older|
|Keywords:||COVID-19, coronavirus, vaccine, vaccine study, Novavax, SARS-CoV-2|
The study has 8-10 required visits and will last about 26 months. The study has a Screening, Injection, & COVID-19 Surveillance and Follow-up period. The first four visits will occur within the first 3 months. After this, the visits are approximately one visit every 6 months for the rest of the study. You will receive either the study vaccine or a placebo. A placebo does not contain any active ingredient.
The procedures in this study include:
two injections given 3 weeks apart into your upper arm
swabs of your nose (nasal swabs) if you develop symptoms of COVID-19
keeping records of your body temperature and symptoms of COVID-19 (if any)
There are other procedures done and other health information collected during this study. The study team will check to see if you qualify to take part in the study. Qualified participants will receive detailed information about the study. This will include a list of study-related tests and procedures.
Each participant must meet the following criteria to take part in this study:
Participants meeting any of the following criteria cannot take part in this study:
There are other requirements to participate in the study. The study team will determine if you are eligible to take part in this study. They will review the full eligibility criteria with you.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.